Chemoinformaics analysis of (2S)-2-(DIMETHYLAMINO)-3-(1H-INDOL-3-YL)PROPANOIC ACID
Molecular Weight | 232.283 | nRot | 4 |
Heavy Atom Molecular Weight | 216.155 | nRig | 3 |
Exact Molecular Weight | 232.121 | nRing | 2 |
Solubility: LogS | -5.23 | nHRing | 1 |
Solubility: LogP | 6.652 | No. of Aliphatic Rings | 0 |
Acid Count | 1 | No. of Aromatic Rings | 2 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 9 |
No. of Oxygen atom | 2 | No. of Arom Bond | 10 |
nHA | 2 | APOL | 36.1827 |
nHD | 2 | BPOL | 19.1993 |
QED | 0.318 |
Synth | 2.292 |
Natural Product Likeliness | 1.187 |
NR-PPAR-gamma | 0.983 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.002 |
HIA | 0.01 |
CACO-2 | -4.733 |
MDCK | 0.0000192 |
BBB | 0.196 |
PPB | 0.983907 |
VDSS | 0.626 |
FU | 0.0161861 |
CYP1A2-inh | 0.235 |
CYP1A2-sub | 0.171 |
CYP2c19-inh | 0.086 |
CYP2c19-sub | 0.066 |
CYP2c9-inh | 0.43 |
CYP2c9-sub | 0.988 |
CYP2d6-inh | 0.006 |
CYP2d6-sub | 0.086 |
CYP3a4-inh | 0.085 |
CYP3a4-sub | 0.019 |
CL | 3.327 |
T12 | 0.628 |
hERG | 0.009 |
Ames | 0.013 |
ROA | 0.01 |
SkinSen | 0.961 |
Carcinogencity | 0.153 |
EI | 0.98 |
Respiratory | 0.712 |
NR-Aromatase | 0.284 |
Antiviral | No |
Prediction | 0.707624 |